Twist Bioscience CEO sells 1,688 shares for taxes
Twist Bioscience Corp Chief Executive Officer Emily M. Leproust reported an open-market sale of 1,688 shares of common stock at $87.3224 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Twist Bioscience Corp Chief Executive Officer Emily M. Leproust reported an open-market sale of 1,688 shares of common stock at $87.3224 per share. According to the disclosure, this sale was required to cover tax withholding obligations tied to vesting Restricted Stock Units under the company’s equity incentive plans and was not a discretionary trade.
After this transaction, Leproust directly holds 842,919 shares of Twist Bioscience common stock. She also retains employee stock options covering 64,950 underlying shares at an exercise price of $67.85 per share that are outstanding and expire on August 31, 2030.
Insider Trade Summary
Net Seller: 1,688 shares
Net Sell
6 txns
Insider
Leproust Emily M.
Role
Chief Executive Officer
Sold
1,688 shs ($147K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,688 | $87.3224 | $147K |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
Holdings After Transaction:
Common Stock — 842,919 shares (Direct);
Employee Stock Option (right to buy) — 64,950 contracts (Direct)
Footnotes (6)
- F1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- F2. The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- F3. The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- F4. 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- F5. 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- F6. Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.
Key Figures
Shares sold: 1,688 shares
Sale price per share: $87.3224 per share
Shares held after sale: 842,919 shares
+3 more
6 metrics
Shares sold
1,688 shares
Open-market sale to cover tax withholding
Sale price per share
$87.3224 per share
Price for 1,688 common shares sold
Shares held after sale
842,919 shares
Common stock directly owned post-transaction
Outstanding option exercise price
$67.85 per share
Exercise price of remaining employee stock option
Underlying shares on remaining option
64,950 shares
Common shares underlying option expiring August 31, 2030
Net shares sold
1,688 shares
Net buy/sell direction is net-sell in summary
Key Terms
Restricted Stock Units, sell to cover, Employee Stock Option (right to buy), performance stock options, +1 more
5 terms
Restricted Stock Units financial
"to cover tax withholding obligations in connection with the vesting of Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
sell to cover financial
"require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
Employee Stock Option (right to buy) financial
"security_title": "Employee Stock Option (right to buy)""
performance stock options financial
"Represents performance stock options granted to the reporting person on September 1, 2020"
equity incentive plans financial
"Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation"
Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Twist Bioscience (TWST) CEO Emily Leproust report in this Form 4?
Emily Leproust reported an open-market sale of 1,688 shares of Twist Bioscience common stock. The transaction was executed at $87.3224 per share and was linked to tax withholding requirements on vesting Restricted Stock Units under the company’s equity incentive plans.
What stock options does the Twist Bioscience (TWST) CEO still have outstanding?
The CEO retains employee stock options over 64,950 underlying shares of common stock with an exercise price of $67.85 per share. These options are immediately exercisable and are scheduled to expire on August 31, 2030, according to the filing’s derivative security table.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates